Bio-Me's vision is to improve global health by unlocking the potential of our microbiome: the complex habitat of microorganisms in our gut. The microbiome is a crucial piece for understanding human health and diseases. We have developed Precision Microbiome Profiling (PMP™), an analysis technology that enables therapeutic developers and researchers to accurately quantify organisms of the microbiome in a fast and practical way that is suited for clinical applications. Combined with access to a world leading biobank and extensive patient databases, Bio-Me’s PMP™ platform will enable microbiome-based diagnostics, and discovery of novel drug targets to improve health and well-being worldwide. We are an international group with a diverse set of R&D, technical and commercial backgrounds who share the passion to solve the current challenges facing medical development by integrating the microbiome into medicine. Bio-Me is an early-stage company and we are now looking for the right resources to grow with us.
Location Norway
Founded 2017
Employees 1-10
Industries Healthcare & Life Science, Science & Engineering
Stage Go to market
Business model B2B
Funding state Seed


Founder, CEO
Jean-Marc Billod
Founder, COO
Warren Flood
Jean-Marc Billod
Chief Clinical Officer
Runar Vige
Scientist | Industrial PhD
Maria Maseng
Laboratory Scientist
Satya Kuraganti
Senior Scientist
Ana Finzel